CD36 initiates Src signal transduction to promote actin remodeling-involved metastasis of lung adenocarcinoma in high-fat environment

doi:10.21203/rs.3.rs-2525782/v1

Download PDF

Article

CD36 initiates Src signal transduction to promote actin remodeling-involved metastasis of lung adenocarcinoma in high-fat environment

https://doi.org/10.21203/rs.3.rs-2525782/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

High-fat environment facilitates the metastasis of lung adenocarcinoma (LUAD) with unknown mechanism. This work aims to reveal the role of fatty acid transporter CD36 in LUAD cell metastasis upon fatty acid oversupply. In human LUAD cells, palmitic acid (PA) treatment promoted CD36 sarcolemmal translocation, where it activated Rac1 and upregulated MMP-9 through Src-Akt/ERK pathway, resulting in redistribution of cortactin, N-WASP and Arp2/3, and finally led to occurrence of finger-like protrusions of actin on cell surface to enhance cell metastasis. Nude mice fed with normal-chew diet (NCD) and high-fat diet (HFD) were subcutaneously injected with scramble/CD36-shRNA stable tranfected-A549 cells respectively. Compared with NCD mice, the HFD group exhibited higher level of blood free fatty acid (FFA) and cholesterol (TC), developed larger xenograft LUAD tumors and enhanced tumor cell metastatic potential in a CD36-dependent manner, which accompanied by obvious sarcolemmal actin remodeling. Consistently, xenografted and tail vein-injected scramble RNA-A549 cells but not CD36-shRNA-A549 in HFD mice formed metastatic LUAD tumors on the lung. Collectively, our finding demonstrates that CD36 initiates the Src signal transduction to induce actin remodeling in high fat environment, which in turn promotes LUAD cell metastasis. Our finding provides valuable targets for prevention and treatment of LUAD.

Biological sciences/Cancer/Lung cancer/Non-small-cell lung cancer

Health sciences/Biomarkers/Predictive markers

CD36

lung adenocarcinoma (LUAD)

metastasis

actin remodeling

Src

Rac1

high-fat environment

With high morbidity and mortality, lung cancer is still the most common cancer worldwide (1). Specially, the incidence rate of lung adenocarcinoma (LUAD), one of the non-small cell lung cancer (NSCLC), is still rising (2, 3). The main reason for the high incidence of lung cancer is the result of the joint action of environmental and genetic factors (4), and in addition to smoking, other factors can still not be ignored (2). Obesity/overweight and lipid metabolism disorder are becoming more and more popular and caused many health problems, including the increased risk and poor prognosis of many cancers (5–7). One of the main characteristics of obesity is the increase of free fatty acids (FFAs) in blood, and FFAs are essential for tumor growth and development (8–11). Although smoking can lead to general weight loss, studies find that central obesity which particularly concurrent with low body mass index (BMI), large waist circumference, hyperlipidemia and muscle loss, may help identify high-risk populations for lung cancer (12–14).

Fatty acid translocase CD36 is involved in the cellular uptake of long-chain fatty acids and oxidized low-density lipoprotein (15). Fatty acid (FA) uptake and lipid metabolism are essential cellular processes to promote tumorigenesis and tumor progression (16), and CD36 is involved in this process (17, 18). Several studies also suggest that CD36 is over-expressed and drives progression in several cancers (19–23). Our previous studies have demonstrated that Src family member Fyn formed CD36-Fyn complex to regulate fatty acid uptake in skeletal muscle cells (24). Increased expression of Src and its activity, bur not Fyn, have been reported in NSCLC, particularly in LUAD (25). Activated Src is involved in inducing lung cancer cell migration and invasion (26). In this context, we speculate that CD36 might promote LUAD development via Src.

LUAD cell migration and invasion serve as critical parameters of the metastasis cascade leading to high mortality rate(27, 28). Dynamic changes in actin filaments are involved in a wide variety of cellular processes including cell motility (29). The rearranged actin filaments, also termed as actin-remodeling (30), is mainly regulated by members of the Rho family (Rho GTPases, including Rho, Cdc42, Rac and its isoforms) signals to form discrete structures at the cell periphery and mediate attachment to the substratum (31). Those discrete structures are essential for cell migration and invasion (31). Actin-remodeling occurs when dorsal circular ruffles (DCRs) formed at the leading edge of cells, provides a relaxation of static actin structures to form pliable membrane protrusions (30, 32). Rho GTPases, like Rac1 or Cdc42, are required for DCRs formation (33). DCRs are also able to secrete matrix metalloproteinases (MMPs) and enriched with actin assembly proteins, such as Arp2/3, WASP and cortactin, revealing their potential role for the cell metastasis onset (32). However, when LUAD cells facing with a high-fat environment, the role and regulation of CD36 on LUAD cell proliferation and actin remodeling-involved metastasis is poorly understood. We here explore the relationship between lipid metabolism disorder and the LUAD occurrence and development, clarify whether high fat affects the proliferation and metastasis of LUAD cells, and further reveal the molecular mechanism of CD36-regulated LUAD beyond.

CD36 was indispensable for PA-induced LUAD cell proliferation and metastasis

To examine the effect of PA on LUAD cell proliferation, migration and invasion, both NCI-H23 and A549 cells were treated with different concentration of PA (molecular ratio of PA:BSA = 1:3) for different time to optimize the condition of PA treatment. For NCI-H23 cell, 10–500 µM PA with 24 h incubation or 0.1-100µM PA with 48 h incubation significantly enhanced cell viability, while 500 µM PA produced lipotoxicity after 48 hours. For A549 cells, 1–50 µM PA increased cell viability after 24 h or 48 h, but 500 µM PA showed lipotoxicity even at 24 h (Supplementary Fig. S1A and S1B). In the BrdU experiment, NCI-H23 or A549 cells proliferation was significantly enhanced after 6 hours of stimulation with different concentrations of PA (Supplementary Fig. S1C). The above results showed that cells incubated with 500 µM PA for a short time (≤6h) did not exhibit toxicity. Thus, in the following experiments, 500 µM was used in a shorter duration time (≤1h) and 10 µM PA was used in a longer duration time (≥6h) to obtain the best observed effect for both NCI-H23 and A549 cells. With proper concentration and incubation time of PA, we found both cell migration (Supplementary Fig. S1D and S1E) and cell invasion (Supplementary Fig. S1F) were enhanced obviously.

To determine whether the effect of PA depended on CD36, we constructed CD36 knockdown LUAD cell lines (Fig. 1A) and CD36 overexpression LUAD cell lines respectively (Fig. 1B). Both basal and PA-induced lung cell proliferation could be significantly inhibited by CD36 knockdown (Fig. 1C). CD36 overexpression promoted cell proliferation even there was no PA stimulation (Fig. 1D). Surprisingly, contrary to the effect of 10µM PA, 500µM PA elicited lipotoxicity in CD36 overexpressed cells (Fig. 1D), which might due to CD36 overexpression caused excessive intake of fatty acids (lipotoxicity) after high concentration PA treatment. Consistently, CD36 knockdown inhibited 10µM PA-induced cell migration (Fig. 1E, Supplementary Fig. S2) and cell invasion (Fig. 1G). CD36 overexpression not only exhibited a PA-like effect in basal state but also facilitated PA effect in promoting cell migration (Fig. 1F, Supplementary Fig. S2) and invasion (Fig. 1H). These changes further validated the indispensable role of CD36 in PA-induced LUAD carcinogenesis.

Cd36 Translocation To Luad Cell Membrane Was Enhanced By Pa Stimulation

CD36 needs to insert into the cell membrane before it combines with and transport extracellular FA. Na-K ATPase was used to outline the cell membrane. Immunofluorescence (IF) results showed that CD36 largely dispersed in cytosol and less located on the cell membrane in basal state. Under PA stimulation, the sarcolemmal CD36 increased obviously (Fig. 2A). Furthermore, by linear scan the fluorescence intensity of cross cell section with Zeiss microscope software, it confirmed that CD36 translocation to the cell membrane was enhanced by PA treatment, which evidenced by the fluorescence signal peak of CD36 and Na-K ATPase occurred almost at the same site (Fig. 2A). We further extracted cell membrane proteins and found that sarcolemmal CD36 increased to a certain extent in PA-treated LUAD cells (Fig. 2B).

Sarcolemmal Cd36 Interacted With Src Kinase To Initiate Pa-induced Src/akt/erk1/2 Kinase Activation In Luad Cells

The above experiments indicated that CD36 may not only mediate FA uptake, but also initiate carcinogenic signaling events in PA-treated LUAD cells proliferation and metastasis. We then try to further verify CD36 and Src kinase relationship. IF results showed PA treatment promoted CD36 and Src colocalization (Fig. 3A). Combined with the fact that PA induced CD36 translocation to the cell membrane (Fig. 2), we concluded that PA stimulation enhanced colocalization of Src and sarcolemmal CD36 (Fig. 3A). Furthermore, by linear scan the fluorescence intensity of cross cell section, the spatial colocalization of Src with CD36 was found to be increased under PA treatment, which evidenced by the fluorescence signal peak of CD36 and Src occurred almost at the same site (Fig. 3A). Immunoprecipitation results confirmed that CD36 interacted with Src under PA treatment (Fig. 3B and 3C). The phosphorylation of Src-Tyr416 increased while Src-Tyr527 decreased, indicating that Src could be activated upon PA treatment (Fig. 3D). At the same time, the activity of Akt and ERK1/2 increased too (Fig. 3D). SSO, a fatty acid analogue as CD36 blocker, effectively blocked the kinases activation induced by PA (Fig. 3D). Moreover, Src kinase inhibitor dasatinib effectively blocked PA-induced activation of Src, Akt and ERK1/2 (Fig. 3D), suggesting that Src kinase located upstream of Akt and ERK1/2 to regulate their activity. Therefore, PA-mediated CD36 sarcolemmal migration enhanced CD36 colocalization with Src kinase, leading to Src kinase activation, which followed by Akt and ERK1/2 activation. The results demonstrated that CD36 was indispensable for PA to activate Src/Akt/ERK1/2 signal axis.

Cd36 Sarcolemmal Distribution And The Followed Src Activation Were Indispensable For Pa-induced Actin Remodeling

The dynamic change of actin structure is required for cell metastasis. Actin-remodeling are involved in a wide variety of cellular processes including cell motility (29). In order to find out whether CD36 played an important role in PA-induced actin remodeling, we firstly observed the dynamic change of actin structure in LUAD cells under PA treatment. IF staining showed that, compared with PA-untreated cells, actin just beneath plasma membrane underwent structural remodeling to protrude out of the membrane and formed finger-like protrusion in PA-treated LUAD cells, where the sarcolemmal CD36 increased obviously (Fig. 4A and 4B). The activity of Src, Akt and ERK1/2 kinase was increased in PA-treated cells. The kinase activity could be further activated in CD36OE cells while blocked in ShCD36 cells (Fig. 4C), indicating that CD36 was pivotal for PA to activate Src/Akt/ERK1/2 signal axis. Consistence with this, actin-remodeling induced by PA disappeared when CD36 was knockdown (Fig. 4D and 4E). And PA could not induce finger like actin-remodeling on the cell surface when CD36 inhibitor SSO or Src inhibitor dasatinib/SU6656 was applied (Fig. 4F). The above experiments proved that PA-induced CD36 sarcolemmal translocation and Src activation regulated actin structural remodeling.

Cd36 Mediated Pa-induced Actin Remodeling Through Rac1

Rho GTPases play an important role in the regulation of actin structure. In order to verify whether Rho family members participate in PA-induced actin remodeling in a CD36-Src signal dependent manner, we detected the change of PA-induced expression/activity of Rho family members Rac1, RhoA and Cdc42 as indicated in Fig. 5A. Although the expression of the three Rho family members did not change obviously, the activity of Rac1 but not RhoA or Cdc42 increased significantly after PA treatment, suggesting that Rac1 was most likely to participate in the PA-induced actin remodeling in LUAD cells (Fig. 5A). CD36 inhibitor SSO, Src inhibitor dasatinib and Akt inhibitor API2 could effectively inhibit PA-induced Rac1 activation, respectively (Fig. 5A and 5B). While ERK inhibitor U0126 could not block the effect of PA on Rac1 (Fig. 5B). Thus, PA-induced Rac1 activation was in a CD36-Src-Akt dependent manner in LUAD cells (Fig. 5A and 5B). Next, we examined the distribution of Rac1, RhoA and Cdc42 and their association with actin protrusions upon PA stimulation. The results showed it was Rac1 (Fig. 5C) but not RhoA and Cdc42 (Supplementary Fig. S3) that partially colocalized with the finger like actin remodeling on the surface of LUAD cells. Next, the LUAD cells were transiently transfected with HA-tagged Rac1 WT, Rac1 DN and Rac1 CA respectively and then were immune-stained with HA antibody (cells with green fluorescence exhibited successful transfection) and actin antibody. This investigation proved that the PA effect on actin remodeling disappeared in LUAD cells transfected with the Rac1 DN plasmid, while PA treatment promoted actin structural remodeling both in the Rac1 WT or Rac1 CA transfected LUAD cells (Fig. 5D). Therefore, Rac1 activity enhanced by PA through the CD36-Src-Akt signaling pathway played the key role in mediating actin-remodeling and promoting tumor metastasis.

PA stimulated redistribution of MMP-9, α-tubulin, Arp2/3 and cortactin closely related to actin remodeling.

Next, we examined the proteins related to actin assembly(34). Our results showed that Arp2 and Arp3 involved in actin remodeling formation were relocated at the root of the formed actin protrusion under PA stimulation (Fig. 6A and Supplementary Fig. S4A). Further investigation proved that Arp2 relocation disappeared in Rac1 DN plasmid-transfected LUAD cells under PA treatment, indicating that Rac1 was upstream of Arp2 in PA-inducing actin remodeling (Fig. 6B). MMP-9 expression was significantly increased under PA stimulation, and both Akt inhibitor API2 and ERK inhibitor U0126 could effectively inhibited MMP-9 induced by PA respectively (Fig. 6C). Thus, MMP-9 induced by PA in LUAD cells was in a CD36-Src-ERK/Akt dependent manner. The further investigation showed that PA induced MMP-9 locating at the tip of the actin protrusions on the cell membrane surface (Fig. 6D). This is consistent with the characteristics of invasive processes since MMP-9 can degrade the extracellular matrix to help cell penetrate into the extracellular matrix (34). The distribution of cortactin also changed to the cell membrane and gathered at the root of actin protrusions under PA stimulation, and some cortactin colocalized with actin protrusions (Fig. 6E). The same tendency happened on N-WASP distribution (Supplementary Fig. S4B). In addition, the distribution of tubulin was mainly in the root of the protrusion (Supplementary Fig. S4C), which provided some support for the protrusion (35). Given the evidence that CD36 mediated PA-induced actin remodeling (Fig. 4), we could speculate that PA changed the distribution of MMP-9, tubulin, N-WASP, cortactin and Arp2/3 through CD36-Src-Akt/ERK signaling pathway to trigger actin structural remodeling in LUAD cells, and finally promote the invasion of tumor cells.

CD36 played the key role to promote tumorigenic properties of LUAD cells in HFD-feeding nude mice

We generated subcutaneous xenograft models to confirm the tumor-promoted function of CD36 in HFD-feeding nude mice. In Fig. 7A, tumor volume derived from A549-scramble cell transplanted HFD mice was significantly larger than that of NCD mice (p < 0.05). A549-ShCD36 cells transplanted into NCD mice and even into HFD mice exhibited markedly decreased tumor growth (p < 0.01 and p < 0.05 respectively). Moreover, tumor volume derived from A549-ShCD36 cells transplanted into HFD mice was significantly smaller than that of A549-Scramble cells transplanted into HFD mice (p < 0.01). These results indicated that knockdown of CD36 significantly counteracted the facilitation of HFD on LUAD tumor growth. Pathologic analysis revealed that relative to A549-Scramble tumors in NCD mice, A549-Scramble tumors in HFD mice were poorly differentiated, more aggressive and contained highly heterogeneous cell types (spindle cells, cells with high nuclear-cytoplasm ratio, and mitotic cells). Whereas, A549-ShCD36 tumors in NCD mice and even in HFD mice retained well-differentiated glandular structures with more loosely arranged cells, when compared with A549-Scramble in NCD and HFD mice (Fig. 7B). High-fat environment in HFD mice was confirmed by the elevated blood FFA and TC after HFD feeding (Fig. 7C). In most of A549-Scramble tumor cells in NCD mice, actin filaments were well organized and distributed evenly throughout the cells. This situation was similar as A549-ShCD36 tumor cells in NCD mice (Fig. 7D). In HFD mice, the actin filaments of A549-Scramble tumor cells formed filopodia, one of the cell motility structures, at the leading edge of the cells, which nearly disappeared in A549-ShCD36 tumor cells in HFD mice (Fig. 7D). The distribution of Arp2 and Arp3 was increased at the root of the formed actin protrusions and partially colocalized with actin-remodeling in A549-Scramble tumor cells in HFD mice (Fig. 7E and Supplementary Fig. S5).

CD36 played the key role to promote metastatic properties of LUAD cells in HFD-feeding nude mice

After removing of subcutaneous tumors, the mice were then kept feeding and sacrificed 12 weeks later to investigate oncogenic effect of CD36 on LUAD cell metastasis. Results showed that A549-Scramble cells in HFD mice exhibited a significantly increased metastatic ability to the lung (p < 0.05 vs. Scramble NCD), while CD36 knockdown decreased LUAD cell metastasis in HFD groups (p < 0.05 vs. Scramble HFD) (Fig. 8A). Pathologic analysis revealed that nodules formed by A549-Scramble cell metastasis to the lung of NCD mice was in neoplasia stage, and nodules formed by A549-Scramble cell metastasis to the lung of HFD mice showed well developed LUAD tumors. A549-ShCD36 cells xenografted in NCD mice did not show obvious metastatic nodules in the lung, and nodules formed by A549-ShCD36 cell metastasis to the lung of HFD mice were still in neoplasia stage (Fig. 8B). The corresponding IHC staining results showed that CD36 expression level was higher in the neoplasia cells, and especially much higher in LUAD tumors, when compared with that in the normal lung cells of ShCD36 NCD mice (Fig. 8C), indicating that higher CD36 expression was accompanied with the development of the metastatic tumor.

To further investigate the oncogenic effect of CD36 on LUAD cell metastasis, the A549-Scramble and A549-ShCD36 cells were inoculated into nude mice feeding with NCD or HFD via tail-vein injection, respectively. The mice were sacrificed 12 weeks later to examine metastatic nodules in lung, liver and spleen. A549-Scramble cells in HFD mice exhibited a significantly increased metastatic ability to the lung (p < 0.05 vs. Scramble NCD), while A549-ShCD36 cells decreased in the total metastatic nodule number in the lung of HFD mice (p < 0.05 vs. Scramble HFD) (Fig. 8D). HE staining results revealed that A549-Scramble tumor in lung of NCD mice was smaller with more loosely arranged cells, while A549-Scramble nodules in lung of HFD mice had already developed into larger mature LUAD tumors. Lung nodules derived from A549-ShCD36 cell tail-vein injection in HFD mice were still in neoplasia stage. No nodules could not be seen in NCD mice (Fig. 8E). Consistence with the in situ tumorigenic lung metastasis model (Fig. 8C), when compared with that in the normal lung cells of ShCD36 NCD mice, CD36 expression 1) in A549-Scramble loosely arranged tumor cells in lungs of NCD mice, 2) in A549-Scramble tumor marginal cells that were invading the surroundings in lungs of HFD mice, and 3) in A549-ShCD36 neoplasia cells in lungs of HFD mice, were in higher levels (Fig. 8F), indicating that CD36 high expression was accompanied with the development of the metastatic tumor. It was worth mentioning that CD36 expression in the mature and closely aligned tumor cells located inside the tumor body, that is, those cancer cells most probably under necrosis in the tumor, was significantly reduced (Fig. 8F). We didn’t find metastatic nodules in the liver and spleen of nude mice (data not shown). These results demonstrated that 1) LUAD tumor cells of tail-vein injection metastasized faster than those injected in situ and developed into mature lung tumors earlier; 2) CD36 exhibited its role in promoting the metastasis and invasion of LUAD cells, especially in lipid-oversupply condition.

Our results showed that lipid oversupply promoted the formation and metastasis of LUAD tumors in a CD36-Src-Akt/ERK signal dependent manner (Fig. 7 and Fig. 8). PA stimulation promoted LUAD cell proliferation, migration and invasion, and CD36 was indispensable in these process (Fig. 1). Though we cannot ignore that CD36-mediated FA uptake promotes the FAs metabolism to provide energy for tumor cell proliferation and metastasis (36), it is more likely that CD36 can induce signal transduction in cells as a cell membrane protein. In our study, upon PA stimulation, CD36 translocated from cytoplasm to LUAD cell membrane, and interacted with Src kinase followed by Src activation. Akt and ERK, locating downstream of Src, were then activated (Fig. 2 and Fig. 3). Consistence with our finding, there is report that CD36 can promote the growth of cervical cancer by activating Src and ERK signaling pathways (11). Also, CD36 is a key mediator of exogenous FA-induced gastric cancer metastasis (10). Further, activation of Akt and ERK1/2 signal transduction pathways regulates tumor-associated FASN gene expression, which confers growth and survival advantages in various tumors (37).

Approximately 70% of lung cancer patients have advanced or metastatic disease that leads to poor prognosis and low 5-year survival rates (38). Tumor metastasis occurs via a series of steps including detachment from the primary tumor, migration and invasion into surrounding tissue, intravasation to blood circulation, and finally extravasation to form new tumor colonies at secondary sites (39). In recent years, attentions have been given to Rac1-GTP enzymes in regulating the reorganization of cytoskeleton proteins, which contributes to the malignant transformation, adhesion, migration and invasion (40–42). We presented here that Rac1 activity but not RhoA or Cdc42 was increased significantly by PA treatment through CD36-Src-Akt signaling pathway, suggesting that Rac1 participated in triggering actin-remodeling and promoting LUAD tumor metastasis (Fig. 5). The finding is in line with that Rac1 overexpresses in various tumors is closely associated with tumor migration, invasion and poor prognosis of carcinomas (43). Functional activities of Rac1 correlating with the enhanced activation of Akt and GSK3β play an important role in lung cancer metastasis (44). Down-regulated Rac1 expression or loss of its function significantly suppressed cancer cell proliferation and metastasis (45). Furthermore, our results showed that Arp2 and Arp3 were involved in actin remodeling formation, in which Rac1 was upstream of Arp2/3 (Fig. 6A and 6B and Supplementary Fig. S4A). MMP-9 induced by PA in LUAD cells was in a CD36-Src-ERK/Akt dependent manner and mainly located at the tips of the actin protrusions on cell surface (Fig. 6C and Fig. 6D). Cortactin and N-WASP have been reported to be regulated by Src kinase (46). IF staining showed the distribution of cortactin and N-WASP changed under PA stimulation, as cortactin translocated to the cell membrane and gathered at the root of actin protrusions (Fig. 6E), while some N-WASP proteins colocalized with actin (Supplementary Fig. S4). Thus, PA activated Rac1 through CD36-Src-Akt signaling pathway, regulated MMP-9 expression through CD36-Src-Akt/ERK signaling pathway, and then changed the distribution of tubulin, N-WASP, cortactin and Arp2/3 in LUAD cells to trigger actin structural remodeling, and finally promote tumor cells metastasis.

A growing body of evidence suggests that combating cancer metastasis by inhibiting migration and invasion is the key to successful cancer treatment (47, 48). Our results indicated that targeting inhibition or down-regulation of CD36 in LUAD cells significantly reduced tumor cell proliferation and metastasis, in which Src-Akt/Erk signaling and Rac1 activation-induced actin remodeling were involved. Consistent with ours, Pascual et al. reports that the use of neutralizing antibodies to block CD36 causes almost complete inhibition of metastasis in mouse models of human oral cancer (19). The therapeutic strategy on targeting CD36 and CD36-Src-Akt/ERK signaling may have effective inhibitory effects on LUAD tumor growth and metastasis.

In conclusion, CD36 functions as the initiator of CD36-Src-Akt/ERK signaling pathway in high-fat environment, which activates Rac1 and finally leads to actin remodeling-involved LUAD cell metastasis. These findings provide valuable targets for prevention and treatment of LUAD.

Cell culture, plasmids transfection and establishment of stable cell lines

Lung cancer cell lines NCI-H23 and A549 were purchased from the American Type Culture Collection (ATCC). Lentivirus vectors containing one scramble and three shRNAs for CD36 were purchased from Origene Biotechnology Co., Ltd (Rockville, MD). The CD36 knockdown effect of the three shRNAs were tested and the shRNA (5'-GGACCATTGGTGATGAGAAGGCAAACATG-3') given the best inhibition effect was selected. Then the plasmids (pLent-U6-GFP-Puro) containing the selected CD36 shRNA and scramble-shRNA, or empty vector (pLent-EF1a-FH-CMV-GFP-p2A-Puro) and the CD36-Flag recombinant plasmid were packed into lentivirus respectively by Weizhen Biotechnology Co., Ltd (Shandong, China). NCI-H23 and A549 cells were cultured in DMEM supplemented with 10% inactivated FBS (Invitrogen, Carlsbad, CA) and transfected with lentivirus respectively. Then the transfected cells were selected with 1mg/ml puromycin to produce stable transfected cells (designated as NCI-H23-ShCD36, A549-ShCD36, NCI-H23-Scramble, and A549-Scramble, NCI-H23-CD36OE, A549-CD36OE, NCI-H23-Vector, and A549-Vector respectively). Knockdown or overexpressed efficiency was confirmed at protein levels. For transient transfection, plasmids with HA-tagged wide type Rac1 (Rac1 WT), dominant negative Rac1 (Rac1 DN) and constitutively active Rac1 (Rac1 CA) (UMR cDNA Resource Center, Rolla, MO) were transfected into the cells with lipo3000 according to the instructions. Then the lipo-transfected cells were used after 48 h of transfection.

Assessment of cell viability and cell proliferation

Cell viability and cell proliferation were detected by MTT assay using MTS kit (Progema, Beijing) and Cell Proliferation ELISA, BrdU (colorimetric) kit (Roche, Mannheim, Germany) respectively, according to the manufacturer’s instructions.

Wound healing and transwell assay

Cells under different treatments were incubated with 10 μg/ml mitomycin-C (Sigma, MO) for 2 h and then starved in serum-free medium for 24 h to suppress proliferation. Then cells were used for wound healing or transwell assay as described (49). The scratched monolayers or migrated cells in randomly selected fields were observed by light microscopy (Olympus, Japan) and analyzed by Image J software.

Cell fractionation

Surface protein (Plasma membrane protein), and cytosol protein were extracted for Western blotting according to our previous publication (30). The protein concentration of these subcellular fractions was determined using the Bio-Rad protein assay.

Western-blot (WB) and Co-Immunoprecipitation (Co-IP)

WB and Co-IP were performed as described (24). WB antibodies against CD36 (ab133625) were purchased from Abcam (Cambridge, MA), antibodies against Src (A19119), Rac1 (A5539), Cdc42 (A1188) and RhoA (A15641) were from Abclonal (Wuhan, China), antibodies against p-Src-Tyr416 (6943S), p-Src-Tyr527 (2105S), p-Akt473 (9271S), Akt (9272S), p-ERK1/2 (4370S), ERK1/2 (4695S), MMP-9 (13667S), GAPDH (5174S), anti-mouse (7076) and anti-rabbit (7074) HRP-linked IgGs, were purchased from Cell Signaling (Boston, MA). Rac1 activation Kit (80501), RhoA activation Kit (80601) and Cdc42 activation Kit (80701) were purchased from NewEast Biosciences (Malvern, PA). IP antibodies against CD36 (sc-7309) and Src (sc-5266) were from Santa Cruz (Dallas, TX).

Immunofluorescence (IF), Immunohistochemistry (IHC) and haematoxylin-eosin (H&E) staining

After proper treatments, cells were fixed with 3% paraformaldehyde in PBS. The tissues in formalin-fixed paraffin sections were sliced to 5μm thickness for staining. IF and IHC staining were performed as described previously (49). Primary antibodies of CD36 (A14714), Rac1 (A5539), Cdc42 (A1188) and RhoA (A15641) were from Abclonal (Wuhan, China), Na/K-ATPase (ab32087), Arp2 (ab47654), Arp3 (ab49671) were from Abcam (Cambridge, MA), MMP-9 (13667S), a-tublin (2144S), cortactin (3503S), N-WASP (4848S), HA (3724S) were purchased from Cell Signaling (Boston, MA), Fluor 546 goat anti-rabbit (A11035) / mouse (A11003), Fluor 488 goat anti-rabbit (A11034) / mouse (A11001), Alexa Fluro 546 Phalloidin (A22283) were purchased from Invitrogen (Waltham, MA). CD36 antibody (PAB12463) for IHC was purchased from Abnova (Taibei, TW). 5μm paraffin sections of the tissues were stained with haematoxylin-eosin for 3-5 min. The stained cells were examined using the Leica microscopy (Aperio CS2, Vista, CA) or the Zeiss confocal microscopy LSM880 (Carl Zeiss, Jena, Germany).

Xenograft model

All animal experiments were approved by the Animal Experimentation Ethics Committee of Shenzhen University. The nude mice were fed with normal chew diet (NCD) or high fat diet (HFD) for one week. Then the NCD- or HFD-fed mice were transplanted subcutaneously with A549-Scramble or A549-CD36 shRNA cells (designated as A549-ShCD36 NCD, A549-ShCD36 HFD, A549-Scramble NCD, and A549-Scramble HFD, respectively) for tumorigenicity and metastasis assay. Briefly, the designated cells (1x10⁶) were S.C. implanted into the left and right dorsal flank of 4-week-old male nude mice (nu/nu, n=10/group, randomized group), respectively. Subcutaneous tumors were measured in two dimensions by external caliper and Tumor volume (V) was estimated by formula [length x width (mm)²]/2 (49). The size of tumor was monitored for 5 weeks, then the tumors were collected while the mice were under anesthesia. After suturing, the mice were continued to feed with NCD or HFD for another 12 weeks. The mice were sacrificed by cervical dislocation and tumor metastasis to lung were observed. For further proving lung metastasis formation, 5x10⁵ A549-shCD36 and A549-scramble cells were injected into the lateral tail vein of the NCD- or HFD-fed mice respectively. Mice were sacrificed 12 weeks later, and the lung, liver and spleen of each mice were removed and subjected to formaldehyde fixation and followed by IF, H&E and IHC staining.

Analysis of mice lipid profiles

Plasma free fatty acids (FFAs) (Wako 294-63601, Osaka, Japan), triglyceride (TG) (BioSino 192061, Beijing, China) and total cholesterol (TC) (BioSino 208051, Beijing, China) were measured by enzymatic colorimetric kits according to the products instructions.

Statistical Analysis

Statistical analyses were performed using GraphPad Prism, version 6.0 (GraphPad Software). To compare the difference between two groups, independent sample t test was used. p< 0.05 was considered statistically significant.

Competing interests

The authors declare that they have no competing interests.

Data Availability

All relevant data are available from the authors upon request.

Authors’ contributions

LZ Liu, MY Li and M Dong designed and supervised the experiment. BW Wang, R Zhang, ZS Wu and JB Yi developed the methodology. LZ Liu, BW Wang, YX Huang, XY Zhang, J Shen and JY Zhou performed the experiments. LZ Liu, MY Li and M Dong analyzed the data, wrote and revised the manuscript.

Funding

This work was supported by grants from the National Natural Science Foundation of China (No: 82072584), Shenzhen University Stable Support Project (20200813175957001), Shenzhen Basic Research General Project (20220523193414003) and Start-up Foundation of Guangzhou National Laboratory. The authors have no additional financial interests.

Competing interests

The authors declare that they have no competing interests.

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
Schuller HM. The impact of smoking and the influence of other factors on lung cancer. Expert Rev Respir Med. 2019;13(8):761–9.
Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22.
Li MY, Liu LZ, Dong M. Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis. Mol Cancer. 2021;20(1):22.
Malik VS, Willet WC, Hu FB. Nearly a decade on - trends, risk factors and policy implications in global obesity. Nat Rev Endocrinol. 2020;16(11):615–6.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body Fatness and Cancer–Viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.
Currie E, Schulze A, Zechner R, Walther TC, Farese RV, Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 2013;18(2):153–61.
Santos CR, Schulze A. Lipid metabolism in cancer. FEBS J. 2012;279(15):2610–23.
Pan J, Fan Z, Wang Z, Dai Q, Xiang Z, Yuan F, et al. CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3beta/beta-catenin pathway. J Exp Clin Cancer Res. 2019;38(1):52.
Yang P, Su C, Luo X, Zeng H, Zhao L, Wei L, et al. Dietary oleic acid-induced CD36 promotes cervical cancer cell growth and metastasis via up-regulation Src/ERK pathway. Cancer Lett. 2018;438:76–85.
Yu D, Zheng W, Johansson M, Lan Q, Park Y, White E, et al. Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis. J Natl Cancer Inst. 2018;110(8):831–42.
Lennon H, Sperrin M, Badrick E, Renehan AG. The Obesity Paradox in Cancer: a Review. Curr Oncol Rep. 2016;18(9):56.
Hidayat K, Du X, Chen G, Shi M, Shi B. Abdominal Obesity and Lung Cancer Risk: Systematic Review and Meta-Analysis of Prospective Studies. Nutrients. 2016;8(12).
Glatz JFC, Luiken J. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization. J Lipid Res. 2018;59(7):1084–93.
Rohrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16(11):732–49.
Zhao J, Zhi Z, Wang C, Xing H, Song G, Yu X, et al. Exogenous lipids promote the growth of breast cancer cells via CD36. Oncol Rep. 2017;38(4):2105–15.
Glatz JF, Nabben M, Heather LC, Bonen A, Luiken JJ. Regulation of the subcellular trafficking of CD36, a major determinant of cardiac fatty acid utilization. Biochim Biophys Acta. 2016;1861(10):1461–71.
Pascual G, Avgustinova A, Mejetta S, Martin M, Castellanos A, Attolini CS, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature. 2017;541(7635):41–5.
Nath A, Chan C. Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers. Sci Rep. 2016;6:18669.
Pavlovic M, Arnal-Estape A, Rojo F, Bellmunt A, Tarragona M, Guiu M, et al. Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis. J Natl Cancer Inst. 2015;107(12):djv256.
Hale JS, Otvos B, Sinyuk M, Alvarado AG, Hitomi M, Stoltz K, et al. Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression. Stem Cells. 2014;32(7):1746–58.
Nath A, Li I, Roberts LR, Chan C. Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma. Sci Rep. 2015;5:14752.
Zhu B, Li MY, Lin Q, Liang Z, Xin Q, Wang M, et al. Lipid oversupply induces CD36 sarcolemmal translocation via dual modulation of PKCzeta and TBC1D1: an early event prior to insulin resistance. Theranostics. 2020;10(3):1332–54.
Giaccone G, Zucali PA. Src as a potential therapeutic target in non-small-cell lung cancer. Annals of Oncology. 2008;19(7):1219–23.
Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ, et al. NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCiota/FAK loop. Cancer Lett. 2012;318(1):106–13.
Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–18.
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28.
Schmidt A, Hall MN. Signaling to the actin cytoskeleton. Annu Rev Cell Dev Biol. 1998;14:305–38.
Liu LZ, Zhao HL, Zuo J, Ho SK, Chan JC, Meng Y, et al. Protein kinase Czeta mediates insulin-induced glucose transport through actin remodeling in L6 muscle cells. Mol Biol Cell. 2006;17(5):2322–30.
Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998;279(5350):509–14.
Krueger EW, Orth JD, Cao H, McNiven MA. A dynamin-cortactin-Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol Biol Cell. 2003;14(3):1085–96.
Dharmawardhane S, Schurmann A, Sells MA, Chernoff J, Schmid SL, Bokoch GM. Regulation of macropinocytosis by p21-activated kinase-1. Mol Biol Cell. 2000;11(10):3341–52.
Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28(1–2):15–33.
Schoumacher M, Goldman RD, Louvard D, Vignjevic DM. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 2010;189(3):541–56.
Mikalayeva V, Cesleviciene I, Sarapiniene I, Zvikas V, Skeberdis VA, Jakstas V, et al. Fatty Acid Synthesis and Degradation Interplay to Regulate the Oxidative Stress in Cancer Cells. Int J Mol Sci. 2019;20(6).
Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–77.
Lu C, Bera K, Wang X, Prasanna P, Xu J, Janowczyk A, et al. A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study. Lancet Digit Health. 2020;2(11):e594-e606.
Bacac M, Stamenkovic I. Metastatic cancer cell. Annu Rev Pathol. 2008;3:221–47.
Kazanietz MG, Caloca MJ. The Rac GTPase in Cancer: From Old Concepts to New Paradigms. Cancer Res. 2017;77(20):5445–51.
Zago G, Biondini M, Camonis J, Parrini MC. A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration. Small GTPases. 2019;10(5):323–30.
Xia L, Lin J, Su J, Oyang L, Wang H, Tan S, et al. Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition. Onco Targets Ther. 2019;12:5713–28.
Leng R, Liao G, Wang H, Kuang J, Tang L. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome. Med Oncol. 2015;32(2):329.
Seiz JR, Klinke J, Scharlibbe L, Lohfink D, Heipel M, Ungefroren H, et al. Different signaling and functionality of Rac1 and Rac1b in the progression of lung adenocarcinoma. Biol Chem. 2020;401(4):517–31.
Nie F, Wang XF, Zhao SY, Bu L, Liu XH. Gene silencing of Rac1 with RNA interference mediated by ultrasound and microbubbles in human LoVo cells: evaluation of cell invasion inhibition and metastatic. J Drug Target. 2015;23(4):380–6.
Shimamura S, Sasaki K, Tanaka M. The Src substrate SKAP2 regulates actin assembly by interacting with WAVE2 and cortactin proteins. J Biol Chem. 2013;288(2):1171–83.
Steeg PS, Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol. 2008;5(4):206–19.
Chanvorachote P, Chamni S, Ninsontia C, Phiboonchaiyanan PP. Potential Anti-metastasis Natural Compounds for Lung Cancer. Anticancer Res. 2016;36(11):5707–17.
Li MY, Liu LZ, Li W, Ng CSH, Liu Y, Kong AWY, et al. Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis. J Exp Clin Cancer Res. 2019;38(1):359.

There is NO conflict of interest to disclose.

SupplementaryFigureswithFigurelegends.pdf

Download PDF

Version 1

posted

You are reading this latest preprint version

CD36 initiates Src signal transduction to promote actin remodeling-involved metastasis of lung adenocarcinoma in high-fat environment

Status:

Version 1

Abstract

Figures

Introduction

Results

CD36 was indispensable for PA-induced LUAD cell proliferation and metastasis

Cd36 Translocation To Luad Cell Membrane Was Enhanced By Pa Stimulation

Sarcolemmal Cd36 Interacted With Src Kinase To Initiate Pa-induced Src/akt/erk1/2 Kinase Activation In Luad Cells

Cd36 Sarcolemmal Distribution And The Followed Src Activation Were Indispensable For Pa-induced Actin Remodeling

Cd36 Mediated Pa-induced Actin Remodeling Through Rac1

Discussion

Materials And Methods

Declarations

References

Additional Declarations

Supplementary Files

Status:

Version 1